Sei Investments CO Agios Pharmaceuticals, Inc. Transaction History

Sei Investments CO

$89.6 Billion
Q3 2025

A detailed history of Sei Investments CO transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 32,300 shares of AGIO stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,300

Previous 10,326 212.8%

Holding current value

$1.41 Million

Previous $343,000 277.84%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$34.37 - $40.61 $755,246 - $892,364	21,974 Added 212.8%	32,300 $1.3 Million
Q2 2025 Aug 14, 2025	SELL	$24.53 - $35.75 $83,917 - $122,300	-3,421 Reduced 24.89%	10,326 $343,000
Q1 2025 May 14, 2025	BUY	$29.3 - $35.9 $1,670 - $2,046	57 Added 0.42%	13,747 $402,000
Q1 2025 May 13, 2025	BUY	$29.3 - $35.9 $2,607 - $3,195	89 Added 0.65%	13,690 $401,000
Q4 2024 Feb 11, 2025	SELL	$32.86 - $61.64 $314,404 - $589,771	-9,568 Reduced 41.3%	13,601 $446,000

Q3 2024 Nov 12, 2024	SELL	$41.19 - $49.72 $8,608 - $10,391	-209 Reduced 0.89%	23,169 $1.03 Million
Q2 2024 Aug 13, 2024	BUY	$27.55 - $48.83 $644,063 - $1.14 Million	23,378 New	23,378 $1.01 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $10,913 - $12,624	-448 Reduced 4.39%	9,752 $241,000
Q2 2023 Aug 11, 2023	SELL	$21.38 - $29.19 $32,882 - $44,894	-1,538 Reduced 13.1%	10,200 $288,000
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $255,184 - $363,056	11,738 New	11,738 $269,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $22,065 - $38,612	1,131 Added 11.64%	10,847 $307,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $165,754 - $305,276	9,716 New	9,716 $213,000
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $184,934 - $311,224	-6,252 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $735,947 - $1.02 Million	-17,556 Reduced 73.74%	6,252 $253,000
Q2 2021 Aug 06, 2021	SELL	$52.06 - $61.27 $55,548 - $65,375	-1,067 Reduced 4.29%	23,808 $1.28 Million
Q1 2021 May 12, 2021	SELL	$44.23 - $57.5 $7,297 - $9,487	-165 Reduced 0.66%	24,875 $1.09 Million
Q4 2020 Feb 08, 2021	SELL	$33.21 - $46.54 $206,267 - $289,059	-6,211 Reduced 19.87%	25,040 $1.04 Million
Q3 2020 Dec 04, 2020	SELL	$33.87 - $55.93 $371,757 - $613,887	-10,976 Reduced 25.99%	31,251 $1.07 Million
Q3 2020 Nov 06, 2020	SELL	$33.87 - $55.93 $124,810 - $206,102	-3,685 Reduced 8.03%	42,227 $1.45 Million
Q2 2020 Aug 17, 2020	BUY	$34.45 - $53.48 $311,979 - $484,314	9,056 Added 24.57%	45,912 $2.45 Million
Q2 2020 Aug 11, 2020	BUY	$34.45 - $53.48 $968,320 - $1.5 Million	28,108 Added 321.31%	36,856 $1.93 Million
Q1 2020 May 14, 2020	BUY	$31.52 - $53.81 $4,381 - $7,479	139 Added 1.61%	8,748 $284,000
Q4 2019 Feb 06, 2020	SELL	$30.08 - $50.59 $20,304 - $34,148	-675 Reduced 7.27%	8,609 $385,000
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $16,167 - $24,740	499 Added 5.68%	9,284 $269,000
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $2,216 - $3,268	-48 Reduced 0.54%	8,785 $412,000
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $120,402 - $177,430	-2,622 Reduced 22.89%	8,833 $585,000
Q4 2018 Feb 13, 2019	BUY	$42.73 - $76.53 $30,936 - $55,407	724 Added 6.75%	11,455 $837,000
Q3 2018 Nov 08, 2018	BUY	$71.67 - $91.95 $116,965 - $150,062	1,632 Added 17.94%	10,731 $825,000
Q2 2018 Aug 03, 2018	BUY	$73.22 - $99.55 $478,858 - $651,057	6,540 Added 255.57%	9,099 $767,000
Q1 2018 May 11, 2018	SELL	$59.83 - $86.53 $18,547 - $26,824	-310 Reduced 10.81%	2,559 $210,000
Q4 2017 Feb 08, 2018	BUY	$52.12 - $72.33 $145,154 - $201,439	2,785 Added 3315.48%	2,869 $164,000
Q3 2017 Nov 06, 2017	BUY	$54.89 - $67.12 $4,610 - $5,638	84	84 $5,000

Others Institutions Holding AGIO

# of Institutions

256

Shares Held

63.8M

Call Options Held

2.06M

Put Options Held

911K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.39B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Agios Pharmaceuticals, Inc. Transaction History